This inventor holds 6 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1989-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989-2003
Title: The Innovations of Theodore Arsay Sheliga
Introduction
Theodore Arsay Sheliga is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of activated protein C. With a total of 6 patents to his name, Sheliga's work has advanced the understanding and application of this important protein.
Latest Patents
Sheliga's latest patents focus on the development of activated protein C formulations. One of his inventions relates to pharmaceutical formulations of activated protein C that are more stable than existing options. These formulations demonstrate fewer degradation products over time, which is crucial for maintaining efficacy. Another patent addresses a method for reducing autodegradation of activated protein C during processing and purification. This invention provides aqueous activated protein C solutions and an improved method of processing, which involves conducting the processing at an ionic strength greater than 150 mM and at a pH of about 5.5 to less than 6.3.
Career Highlights
Theodore Arsay Sheliga is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly has allowed him to focus on innovative solutions that enhance the stability and effectiveness of activated protein C formulations.
Collaborations
Throughout his career, Sheliga has collaborated with several talented individuals, including Andrew David Carlson and Jeffrey C Baker. These collaborations have contributed to the successful development of his patented technologies.
Conclusion
Theodore Arsay Sheliga's contributions to the field of pharmaceutical formulations, particularly in activated protein C, highlight his innovative spirit and dedication to advancing medical science. His work continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
